Poly(ADP-ribose) protects vascular smooth muscle cells from oxidative DNA damage
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Vascular smooth muscle cells (VSMCs) undergo death during atherosclerosis, a widespread cardiovascular disease. Recent studies suggest that oxidative damage occurs in VSMCs and induces atherosclerosis. Here, we analyzed oxidative damage repair in VSMCs and found that VSMCs are hypersensitive to oxidative damage. Further analysis showed that oxidative damage repair in VSMCs is suppressed by a low level of poly (ADP-ribosyl)ation (PARylation), a key post-translational modification in oxidative damage repair. The low level of PARylation is not caused by the lack of PARP-1, the major poly(ADP-ribose) polymerase activated by oxidative damage. Instead, the expression of poly(ADP-ribose) glycohydrolase, PARG, the enzyme hydrolyzing poly(ADP-ribose), is significantly higher in VSMCs than that in the control cells. Using PARG inhibitor to suppress PARG activity facilitates oxidative damage-induced PARylation as well as DNA damage repair. Thus, our study demonstrates a novel molecular mechanism for oxidative damage-induced VSMCs death. This study also identifies the use of PARG inhibitors as a potential treatment for atherosclerosis.
Abstract
Vascular smooth muscle cells (VSMCs) undergo death during atherosclerosis, a widespread cardiovascular disease. Recent studies suggest that oxidative damage occurs in VSMCs and induces atherosclerosis. Here, we analyzed oxidative damage repair in VSMCs and found that VSMCs are hypersensitive to oxidative damage. Further analysis showed that oxidative damage repair in VSMCs is suppressed by a low level of poly (ADP-ribosyl)ation (PARylation), a key post-translational modification in oxidative damage repair. The low level of PARylation is not caused by the lack of PARP-1, the major poly(ADP-ribose) polymerase activated by oxidative damage. Instead, the expression of poly(ADP-ribose) glycohydrolase, PARG, the enzyme hydrolyzing poly(ADP-ribose), is significantly higher in VSMCs than that in the control cells. Using PARG inhibitor to suppress PARG activity facilitates oxidative damage-induced PARylation as well as DNA damage repair. Thus, our study demonstrates a novel molecular mechanism for oxidative damage-induced VSMCs death. This study also identifies the use of PARG inhibitors as a potential treatment for atherosclerosis.
참고문헌 (36)
- Ragnauth CD, "Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging", Circulation, 121, pp.2200~2210 (2010)
- Gray K, "Role of DNA damage in atherosclerosis--bystander or participant?", Biochem Pharmacol, 82, pp.693~700 (2011)
- Martinet W, "Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering", Circ Res, 88, pp.733~739 (2001)
- Mahmoudi M, "Statins use a novel Nijmegen breakage syndrome-1-dependent pathway to accelerate DNA repair in vascular smooth muscle cells", Circ Res, 103, pp.717~725 (2008)
- Finkel T, "Oxidants, oxidative stress and the biology of ageing", Nature, 408, pp.239~247 (2000)
- Cadet J, "Oxidatively generated base damage to cellular DNA", Free Radical Biol Med, 49, pp.9~21 (2010)
- Olinski R, "Oxidative DNA damage:assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome", Free Radical Biol Med, 33, pp.192~200 (2002)
- Sedelnikova OA, "Role of oxidatively induced DNA lesions in human pathogenesis", Mutat Res-Rev Mutat, 704, pp.152~159 (2010)
- Li M, "Function of BRCA1 in the DNA Damage Response Is Mediated by ADP-Ribosylation", Cancer Cell, 23, pp.693~704 (2013)
- Li M, "The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response", Genes Dev, 27, pp.1752~1768 (2013)
- Schreiber V, "Poly(ADP-ribose) : novel functions for an old molecule", Nat Rev Mol Cell Biol, 7, pp.517~528 (2006)
- Gibson BA, "New insights into the molecular and cellular functions of poly(ADP-ribose)and PARPs", Nat Rev Mol Cell Bio, 13, pp.411~424 (2012)
- Kim MY, "Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal", Genes Dev, 19, pp.1951~1967 (2005)
- de Murcia JM, "Requirement of poly(ADP-ribose)polymerase in recovery from DNA damage in mice and in cells", Proc Natl Acad Sci U S A, 94, pp.7303~7307 (1997)
- Celeste A, "Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks", Nat Cell Biol, 5, pp.675~679 (2003)
- Beyer Nardi N, "Mesenchymal stem cells: isolation, in vitro expansion and characterization", Handb Exp Pharmacol, pp.249~282 (2006)
- Shen H, "The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis", Genes Dev, 20, pp.675~688 (2006)
- Asad NR, "Several pathways of hydrogen peroxide action that damage the E. coli genome", Genet Mol Biol, 27, pp.291~303 (2004)
- Hegde ML, "Oxidative genome damage and its repair:implications in aging and neurodegenerative diseases", Mech Ageing Dev, 133, pp.157~168 (2012)
- Hegde ML, "Early steps in the DNA base excision", single-strand interruption repair pathway in mammalian cells, 2008, pp.18, 27~47
- D'Errico M, "Mechanism of oxidative DNA damage repair and relevance to human pathology", Mutat Res, 659, pp.4~14 (2008)
- Herbert KE, "Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways", Circ Res, 102, pp.201~208 (2008)
- Wang JC, "Aging and atherosclerosis:mechanisms, functional consequences, and potential therapeutics for cellular senescence", Circ Res, 111, pp.245~259 (2012)
- Matsura T, "Hydrogen peroxide-induced apoptosis in HL-60 cells requires caspase-3 activation", Free Radic Res, 30, pp.73~83 (1999)
- Olive PL, "The comet assay: a method to measure DNA damage in individual cells", Nat Protoc, 1, pp.23~29 (2006)
- Zhang C, "Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery", Am J Physiol Heart Circ Physiol, 287, pp.659~666 (2004)
- Forte A, "DNA damage and repair in a model of rat vascular injury", Clin Sci (2009)
- Burkle A, "Physiology and pathophysiology of poly(ADP-ribosyl)ation", Bioessays, 23, pp.795~806 (2001)
- El-Khamisy SF, "A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage", Nucleic Acids Res, 31, pp.5526~5533 (2003)
- Jacobson MD, "Reactive oxygen species and programmed cell death", Trends Biochem Sci, 21, pp.83~86 (1996)
- Martinet W, "Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques", Circulation, 106, pp.927~932 (2002)
- Hassa PO, "The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases", Front Biosci, 13, pp.3046~3082 (2008)
- Zhang H, "Mechanisms controlling the smooth muscle cell death in progeria via down-regulation of poly(ADP-ribose)polymerase 1", Proc Natl Acad Sci U S A, 111, pp.2261~2270 (2014)
- Sodhi RK, "Poly(ADP-ribose)polymerase-1(PARP-1)and its therapeutic implications", Vascul Pharmacol, 53, pp.77~87 (2010)
- Lu XC, "Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat", Brain Res, 978, pp.99~103 (2003)
- Blenn C, "Poly(ADP-ribose)glycohydrolase silencing protects against H2O2-induced cell death", Biochem J, 396, pp.419~429 (2006)